TRONCI, ELISABETTA
 Distribuzione geografica
Continente #
EU - Europa 83.371
NA - Nord America 2.937
AS - Asia 413
SA - Sud America 7
Continente sconosciuto - Info sul continente non disponibili 3
OC - Oceania 2
Totale 86.733
Nazione #
IT - Italia 82.609
US - Stati Uniti d'America 2.919
CN - Cina 270
UA - Ucraina 244
DE - Germania 181
SE - Svezia 166
SG - Singapore 85
FI - Finlandia 60
GB - Regno Unito 53
KR - Corea 25
CA - Canada 16
RU - Federazione Russa 16
VN - Vietnam 12
BE - Belgio 11
FR - Francia 11
IN - India 8
NL - Olanda 8
CZ - Repubblica Ceca 6
HK - Hong Kong 5
BR - Brasile 4
EU - Europa 3
JP - Giappone 3
CL - Cile 2
IE - Irlanda 2
MX - Messico 2
TH - Thailandia 2
TR - Turchia 2
AR - Argentina 1
AT - Austria 1
AU - Australia 1
CH - Svizzera 1
LV - Lettonia 1
MT - Malta 1
NZ - Nuova Zelanda 1
SA - Arabia Saudita 1
Totale 86.733
Città #
Cagliari 79.029
Uta 3.411
Fairfield 420
Woodbridge 360
Ashburn 217
Chandler 212
Ann Arbor 201
Houston 182
Wilmington 179
Cambridge 151
Seattle 151
Jacksonville 126
Nyköping 126
Boardman 117
Dearborn 108
Shanghai 53
Nanjing 52
Beijing 49
Singapore 47
Santa Clara 43
Helsinki 25
Boston 23
New York 23
San Diego 22
Seoul 22
Milan 18
Dong Ket 12
Brussels 11
Guangzhou 11
Nanchang 11
Redwood City 11
Verona 11
Mountain View 10
Shenyang 10
Changsha 9
Hebei 9
Sassari 9
Norwalk 8
Oristano 8
Toronto 8
Falls Church 7
Brno 6
Hefei 6
Los Angeles 6
Padova 6
Central 5
Jinan 5
Rome 5
Tianjin 5
Washington 5
Edinburgh 4
Florence 4
Grottammare 4
Hangzhou 4
Jiaxing 4
London 4
Ningbo 4
Orange 4
Phoenix 4
Pune 4
Zhengzhou 4
Borås 3
Detroit 3
Kilburn 3
Munich 3
Tossicia 3
Ankara 2
Atlanta 2
Auburn Hills 2
Augusta 2
Baotou 2
Brescia 2
Capoterra 2
Chicago 2
Clifton 2
Dublin 2
Fuzhou 2
Kunming 2
Ottawa 2
Palermo 2
Piscataway 2
Redmond 2
San Vittore Olona 2
Sarroch 2
Siena 2
Villacidro 2
Yellow Springs 2
Bangalore 1
Bay Springs 1
Berlin 1
Council Bluffs 1
Elk Grove Village 1
Este 1
Ferrara 1
Forest City 1
Genoa 1
Indiana 1
Lanzhou 1
Leawood 1
Mexico City 1
Totale 85.675
Nome #
5alpha-reductase inhibitors dampen L-DOPA-induced dyskinesia via normalization of dopamine D1-receptor signaling pathway and D1-D3 receptor interaction 5.688
Effect of memantine on L-DOPA-induced dyskinesia in the 6-OHDA-lesioned rat model of Parkinson's disease. 4.224
Pathophysiology of L-dopa-induced motor and non-motor complications in Parkinson's disease 4.186
The 5-alpha reductase inhibitor finasteride reduces dyskinesia in a rat model of Parkinson's disease 3.981
Anti-dyskinetic effect of anpirtoline in animal models of L-DOPA-induced dyskinesia 3.610
Effect of selective and non-selective serotonin receptor activation on l-DOPA-induced therapeutic efficacy and dyskinesia in parkinsonian rats 3.454
Antidyskinetic effect of A2A and 5HT1A/1B receptor ligands in two animal models of Parkinson's disease 3.434
The anti-dyskinetic effect of dopamine receptor blockade is enhanced in parkinsonian rats following dopamine neuron transplantation 3.347
null 2.940
Vitamin A deficiency induces motor impairments and striatal cholinergic dysfunction in rats 2.784
Study of the antidyskinetic effect of eltoprazine in animal models of levodopa-induced dyskinesia 2.490
The serotonergic system in levodopa-induced dyskinesia 2.454
null 2.298
null 2.247
Efficacy and safety of 5-Hydroxytryptophan on levodopa-induced motor complications in Parkinson's disease: A preliminary finding 2.218
5-HT1 receptor agonists for the treatment of L-DOPA-induced dyskinesia: From animal models to clinical investigation 2.137
Foetal cell transplantation for Parkinson's disease: focus on graft-induced dyskinesia 2.094
Serotonin system implication in L-DOPA-induced dyskinesia: from animal models to clinical investigations 2.077
Amphetamine-induced rotation and L-DOPA-induced dyskinesia in the rat 6-OHDA model: A correlation study 2.074
Role of serotonin neurons in L-DOPA- and graft-induced dyskinesia in a rat model of parkinson's disease 2.055
A new ethyladenine antagonist of adenosine A(2A) receptors: behavioral and biochemical characterization as an antiparkinsonian drug 2.015
Caffeine consumption and changes in the function of dopaminergic transmission: evidence of a hyperdopaminergic state in rats subchronically treated with caffeine 1.701
null 1.471
Serotonin neuron-dependent and -independent reduction of dyskinesia by 5-HT1A and5-HT1B receptor agonists in the rat Parkinson model 1.467
BDNF Overexpression Increases Striatal D3Receptor Level at Striatal Neurons and Exacerbates D1-Receptor Agonist-Induced Dyskinesia 1.288
Long-term increase in GAD67 mRNA expression in the central amygdala of rats sensitized by drugs and stress 1.266
Characterization of the antiparkinsonian effects of the new adenosine A2A receptor antagonist ST1535: acute and subchronic studies in rats 1.204
null 1.194
Caffeine sensitization and cross-sensitization with amphetamine: association to post-synaptic changes in rat striatal neurons 1.177
Adenosine A2A and dopamine receptor interactions in basal ganglia of dopamine denervated rats 1.093
Dopamine and adenosine receptor interaction as the basis for the treatment of Parkinson's disease 1.050
Dopamine and adenosine receptor interaction as basis for the treatment of Parkinson's disease 1.018
null 1.012
CAFFEINE SESITIZATION AND CROSS-SENSITIZATION WITH AMPHETAMINE: ASSOCIATION TO POST-SYNAPTIC CHANGES IN RAT STRIATAL NEURONS 985
Effect of serotonin transporter blockade on L-DOPA-induced dyskinesia in animal models of Parkinson's disease 977
CAFFEINE SENSITIZATION AND CROSS-SENSITIZATION WITH AMPHETAMINE: ASSOCIATION TO POST BUT NOT PRE-SYNAPTIC CHANGES IN RAT STRIATAL NEURON 971
null 967
Modulation of serotonergic transmission by eltoprazine in L-DOPA-induced dyskinesia: Behavioral, molecular, and synaptic mechanisms 963
Changes in the expression of tonic and phasic neurochemical markers of activity in a rat model of L-DOPA induced dyskinesia 917
Changes in the expression of tonic and phasic neurochemical markers of activity in a rat model of L-DOPA induced dynskinesia 868
Selective modifications in GAD67 mRNA levels in striatonigral and striatopallidal pathways correlate to dopamine agonist priming in 6-hydroxydopamine-lesioned rats 864
5-Hydroxy-tryptophan for the treatment of l-DOPA-induced dyskinesia in the rat Parkinson's disease model 817
Different responsiveness of striatonigral and striatopallidal neurons to L-DOPA after a subchronic intermittent L-DOPA treatment 812
BDNF over-expression induces striatal serotonin fiber sprouting and increases the susceptibility to L-DOPA-induced dyskinesia in 6-OHDA-lesioned rats 585
Potentiation of amphetamine-mediated responses in caffeine-sensitized rats involves modifications in A2A receptors and zif-268 mRNAs in striatal neurons 243
Subchronic-intermittent caffeine amplifies the motor effects of amphetamine in rats 189
Totale 86.906
Categoria #
all - tutte 99.597
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 99.597


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20203.710 0 0 0 0 0 0 2.038 385 314 297 254 422
2020/202120.096 744 705 817 5.643 4.256 2.287 1.509 1.263 366 959 961 586
2021/20223.592 394 366 173 182 253 273 204 158 271 431 492 395
2022/20235.396 358 594 582 451 475 603 302 358 408 422 567 276
2023/20245.792 231 177 232 295 539 859 907 389 223 409 613 918
2024/202516.155 4.890 4.650 4.172 1.181 592 638 32 0 0 0 0 0
Totale 86.906